ORALAIR® — a sublingual immunotherapy option for grass allergy patients

Indications and Usage

ORALAIR^® is an allergen extract indicated as immunotherapy for the treatment of grass pollen-induced allergic rhinitis with or without conjunctivitis confirmed by positive skin test or in vitro testing for pollen-specific lgE antibodies for any of the 5 grass species contained in this product. ORALAIR is approved for use in persons 10 through 65 years of age.

ORALAIR is not indicated for the immediate relief of allergy symptoms.

Let your grass allergy patients play on with ORALAIR

The All-Points Allergy^TM patient support program reduces patients' co-pays to $25 per prescription, with a maximum annual savings of $1,500^*

Help your patients save on ORALAIR

Let your grass allergy patients play on with ORALAIR

Prescribe the first and only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses indicated for the treatment of confirmed grass pollen-induced allergic rhinitis with or without conjunctivitis in persons 10 through 65 years of age¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

Give your patients the tablet with 5 widespread grasses that mimic their natural exposure

Let your grass allergy patients play on with ORALAIR

The grass mixture in ORALAIR balances the major allergen content of the 5 grasses²

Give your patients a consistent ratio of important major allergens

Let your grass allergy patients play on with ORALAIR

Prescribe a treatment that is effective during the first pollen season, reducing allergy symptoms and use of rescue medications¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

Give your patients efficacy during the first pollen season

Let your grass allergy patients play on with ORALAIR

ORALAIR is another option for your grass allergy patients who discontinue or refuse subcutaneous immunotherapy (SCIT)

Give your patients an important immunotherapy option

Let your grass allergy patients play on with ORALAIR

Help your staff identify appropriate patients for ORALAIR and
maintain open lines of communication to encourage patient
compliance with the GREER^® Grassroots^™ Patient Management
program

Oralair

Indications and Usage

Let your grass allergy patients play on with ORALAIR

The All-Points Allergy^TM patient support program reduces patients' co-pays to $25 per prescription, with a maximum annual savings of $1,500^*

Let your grass allergy patients play on with ORALAIR

Prescribe the first and only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses indicated for the treatment of confirmed grass pollen-induced allergic rhinitis with or without conjunctivitis in persons 10 through 65 years of age¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

Let your grass allergy patients play on with ORALAIR

The grass mixture in ORALAIR balances the major allergen content of the 5 grasses²

Let your grass allergy patients play on with ORALAIR

Prescribe a treatment that is effective during the first pollen season, reducing allergy symptoms and use of rescue medications¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

Let your grass allergy patients play on with ORALAIR

ORALAIR is another option for your grass allergy patients who discontinue or refuse subcutaneous immunotherapy (SCIT)

Let your grass allergy patients play on with ORALAIR

Help your staff identify appropriate patients for ORALAIR and
maintain open lines of communication to encourage patient
compliance with the GREER^® Grassroots^™ Patient Management
program

Download support materials to help you manage your
ORALAIR patients

Let your grass allergy patients play on with ORALAIR

The All-Points AllergyTM patient support program reduces patients' co-pays to $25 per prescription, with a maximum annual savings of $1,500*

Let your grass allergy patients play on with ORALAIR

Prescribe the first and only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses indicated for the treatment of confirmed grass pollen-induced allergic rhinitis with or without conjunctivitis in persons 10 through 65 years of age1

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season1

Let your grass allergy patients play on with ORALAIR

The grass mixture in ORALAIR balances the major allergen content of the 5 grasses2

Let your grass allergy patients play on with ORALAIR

Prescribe a treatment that is effective during the first pollen season, reducing allergy symptoms and use of rescue medications1

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season1

Let your grass allergy patients play on with ORALAIR

ORALAIR is another option for your grass allergy patients who discontinue or refuse subcutaneous immunotherapy (SCIT)

Let your grass allergy patients play on with ORALAIR

Help your staff identify appropriate patients for ORALAIR and maintain open lines of communication to encourage patient compliance with the GREER® Grassroots™ Patient Management program

Download support materials to help you manage your ORALAIR patients

The All-Points Allergy^TM patient support program reduces patients' co-pays to $25 per prescription, with a maximum annual savings of $1,500^*

Prescribe the first and only sublingual grass allergy immunotherapy tablet with a mixed pollens allergen extract from 5 grasses indicated for the treatment of confirmed grass pollen-induced allergic rhinitis with or without conjunctivitis in persons 10 through 65 years of age¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

The grass mixture in ORALAIR balances the major allergen content of the 5 grasses²

Prescribe a treatment that is effective during the first pollen season, reducing allergy symptoms and use of rescue medications¹

Initiate treatment 4 months before the expected onset of each grass pollen season and maintain it throughout the grass pollen season¹

Help your staff identify appropriate patients for ORALAIR and
maintain open lines of communication to encourage patient
compliance with the GREER^® Grassroots^™ Patient Management
program

Download support materials to help you manage your
ORALAIR patients